Skip to main content

IDWeek 2023 Main banner

Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

Hiroshi Yotsuyanagi, MD PhD

The University of Tokyo, Japan

Poster(s):

(548) Combined Results of the Phase 2a/2b/3 Randomized Controlled Trials of Ensitrelvir for the Treatment of COVID-19 Infection

Thursday, October 12, 2023
12:15 PM – 1:30 PM US ET
(549) Ensitrelvir for the Treatment of COVID-19 Infection: Evaluation of Taste Disorder and Smell Disorder in the Phase 3 Part of the Phase 2/3 SCORPIO-SR Randomized Controlled Trial

Thursday, October 12, 2023
12:15 PM – 1:30 PM US ET